Tryp Therapeutics, a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, announced today that it will present at the 2nd Annual H.C. Wainwright Psychedelics Conference.
Compound Psilocybin
Visit article
Category Press Release
Country United States of America
Companies Featured
Tryp TherapeuticsTryp Therapeutics is a clinical stage drug development company developing psilocybin products for various diseases/disorders including fibromyalgia.